Why the study?
Does atrial antitachycardia pacing reduce hospital admissions and antiarrhythmic drug use in patients with recurrent supraventricular tachycardia?
Population
22 patients with recurrent supraventricular tachycardia, mean age 44 +/- 14 years, 82% female, with symptoms…
Design
Case_series
Follow-up
14.8 +/- 11.5 months
Authors
Loading...
May reduce readmissions and drug needs in selected SVT; hypothesis-generating case data, needs prospective confirmation before practice change.
Does atrial antitachycardia pacing reduce hospital admissions and antiarrhythmic drug use in patients with recurrent supraventricular tachycardia?
Atrial antitachycardia pacing is an effective and safe therapy for carefully selected patients with recurrent supraventricular tachycardia, reducing hospital admissions and the need for antiarrhythmic drugs.
McComb et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: